Fundraising FoxE-scape Bio
South San Francisco, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into E-scape Bio
Sign up to find every way you can get introduced to E-scape Bio
- Your email: who you already know at E-scape Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the E-scape Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
JA
Julie Anne SmithExecutive
RS
R. Sanders WilliamsNamed on SEC filing
PK
Perry KarsenNamed on SEC filing
JL
Judith LiNamed on SEC filing
MG
Markus GoebelNamed on SEC filing
PM
Peter MoldtNamed on SEC filing
PT
Peter ThompsonNamed on SEC filing
Board
AX
Investors · 1
Reported raises · per SEC filings
Form D private placements$167.1M disclosed across 3 rounds · 2015–2020
▶$73MraisedSep 2020 · 29 investors · BiotechnologyRule 506(b)
▶$73MraisedSep 2020 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter MoldtDirector
- Carrolee BarlowExecutive Officer
- Paul WrenExecutive Officer
- Asish XavierDirector
- Laura BrassDirector
- Perry KarsenDirector
- Julie Anne SmithExecutive Officer, Director
- R. Sanders WilliamsDirector
- Peter ThompsonDirector
- Anthony RimacExecutive Officer
- Offering amount
- $73M
- Amount sold
- $73M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$31.1MraisedJul 2019 · 22 investors · BiotechnologyRule 506(b)
▶$31.1MraisedJul 2019 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Perry KarsenDirector
- Asish XavierDirector
- Julie Anne SmithExecutive Officer, Director
- Laura BrassDirector
- Peter ThompsonDirector
- Peter MoldtDirector
- R. Sanders WilliamsDirector
- Offering amount
- $35M
- Amount sold
- $31.1M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$63MraisedOct 2018 · 31 investors · BiotechnologyRule 506(b)
▶$63MraisedOct 2018 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- R. Sanders WilliamsDirector
- Perry KarsenDirector
- Asish XavierDirector
- Judith LiDirector
- Markus GoebelDirector
- Peter MoldtDirector
- Julie Anne SmithExecutive Officer, Director
- Peter ThompsonDirector
- Offering amount
- $63M
- Amount sold
- $63M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are E-scape Bio's investors?
- E-scape Bio's investors include OUP (Osage University Partners).
- How much funding has E-scape Bio raised?
- E-scape Bio has disclosed $167.1M raised across 3 rounds.
- Where is E-scape Bio headquartered?
- E-scape Bio is headquartered in South San Francisco, US.